Low molecular weight kininogen (LMWK) shares its heavy chain and bradykinin sequence with HMWK but has a shorter light chain, so it does not take part in contact activation.
Athens Bioscience supplies human LMWK purified from plasma, lyophilized at ≥95% purity by SDS-PAGE. It is used in kinin and tissue kallikrein research, cysteine protease inhibition studies, and immunoassay development. High molecular weight kininogen is also available.
Low molecular weight kininogen (LMWK) shares its heavy chain and bradykinin sequence with HMWK but has a shorter light chain, so it does not take part in contact activation.
Athens Bioscience supplies human LMWK purified from plasma, lyophilized at ≥95% purity by SDS-PAGE. It is used in kinin and tissue kallikrein research, cysteine protease inhibition studies, and immunoassay development. High molecular weight kininogen is also available.
Low Molecular Weight Kininogen (LMWK) is a plasma protein produced through alternative splicing of the KNG1 gene and consists of 427 amino acids. Unlike its high molecular weight counterpart, LMWK is not directly involved in blood coagulation but plays a key role in blood pressure regulation and vascular homeostasis. It serves as an endogenous substrate for tissue kallikrein, which cleaves LMWK to release kallidin-a vasoactive peptide that can be further converted to bradykinin-both of which induce vasodilation and increase vascular permeability, thereby influencing blood pressure and inflammatory responses.
Additionally, LMWK acts as a major extracellular cysteine protease inhibitor, helping regulate protease activity in tissues and contributing to protection against excessive proteolysis. Altered levels or dysfunction of kininogens have been associated with conditions such as inflammation, diabetes, myocardial infarction, and certain cancers. LMWK and its cleavage products are also being explored as potential biomarkers and therapeutic targets in cardiovascular and inflammatory diseases.
Common uses include cardiovascular research, enzymatic and inhibition assays, therapeutics research, IVD Assay standards, calibrators and controls.
Not a hazardous substance or mixture.
11 - Combustible Solids